Sign in

CIK 0001035354

  • Non-accelerated filer
  • Smaller reporting company

Eloxx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELOX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841368850
Phone
+1 781-577-5300
Business address
P.O. BOX 274, ARLINGTON, MA, 02476
Former names
Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2010-11-17 Waksal Harlan Director Grant or award · Common Stock Option +96,154 360,112
2010-11-17 Waksal Harlan Director Grant or award · Common Stock Option +200,000 560,112
2010-11-17 Waksal Harlan Director Grant or award · Common Stock Option +500,000 1,060,112
2010-11-17 BROOKS JOEL CFO and Treasurer Grant or award · Common Stock Option +425,000 882,500
2010-11-17 Browne Leslie J President and CEO Grant or award · Common Stock Option +725,000 1,725,000
2010-11-17 Dondero Richard S VP - Research and Development Grant or award · Common Stock Option +425,000 1,232,924
2010-11-17 Van Hulst Jack Director Grant or award · Common Stock Option +37,177 415,209
2010-11-17 Van Hulst Jack Director Grant or award · Common Stock Option +100,000 515,209
2010-11-17 Van Hulst Jack Director Grant or award · Common Stock Option +50,000 565,209
2010-11-17 Van Hulst Jack Director Grant or award · Common Stock Option +50,000 615,209
2010-11-17 THOMPSON JOHN PHD EVP and CSO Grant or award · Common Stock Option +425,000 995,676
2010-06-02 FORBES CHRISTOPHER Director Purchase · Common Stock Warrant +3,125,000 7,091,477
2010-06-02 FORBES CHRISTOPHER Director Purchase · Series B Convertible Preferred Stock +1,000 $1,000.00 $1.0M 1,000
2010-06-02 Waksal Harlan Director Purchase · Common Stock Warrant +625,000 1,167,333
2010-06-02 Waksal Harlan Director Purchase · Series B Convertible Preferred Stock +200 $1,000.00 $200K 200
2010-05-25 Waksal Harlan Director Grant or award +28,135 $0.37 $10K 178,914
2010-05-25 Waksal Harlan Director Grant or award +12,078 $0.51 $6K 190,992
2010-05-25 Waksal Harlan Director Conversion +631,176 $0.83 $524K 822,168
2010-05-25 Waksal Harlan Director Exercise or conversion · Convertible Debenture Due 12/31/2010 −0 $0.83 $0 0
2010-05-25 BRACA JOHN N Director Grant or award +3,470 $0.37 $1K 58,637

Page 28 of 38 · 754 trades